ORGO (Organogenesis Inc.) Short-Term Debt to Capital

Corporate emblem and logo of Organogenesis (ORGO)

The price trend visualization for Organogenesis Holdings (ORGO) demonstrates the impact of Medicare regulatory risks weighing on profits, with the metric standing at 0.05. The business generates revenue from the production of regenerative products, including cellular joint solutions and skin substitutes. By holding patents in tissue healing, Organogenesis Holdings (ORGO) maintains an exclusive position that allows it to exercise significant pricing power over its services.

ORGO - Organogenesis Corp Short-Term Debt to Capital over the range 07/04/2022 - 11/01/2026

Metric breakdowns and analytics for organogenesis.com (ORGO)

- stock value and consensus price forecast:
Price Chart Organogenesis Inc.|ORGO - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Organogenesis Holdings Inc.|ORGO - Total Enterprise Value
- book capitalization information:
Book Value per Share Organogenesis|ORGO - Book Capitalization|Market Cap to Net Assets Ratio organogenesis.com|ORGO - Aggregate Business Assets
- debt level and financial liquidity data:
Debt to Equity Organogenesis Holdings|ORGO - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Organogenesis|ORGO - Company Cumulative Debt|Debt to Book Capitalization Ratio Organogenesis Holdings Inc.|ORGO - Company Long-Term Indebtedness|Company Current Liabilities Organogenesis|Quick Liquidity organogenesis.com
- earnings and market ratios statistics:
ORGO - Company Net Income
Analysis of all company metrics:ORGO Organogenesis Inc.
Signature product of organogenesis.com

High capacity utilization at Organogenesis Holdings (ORGO) biomedical plants and the modernization of sterility lines necessitate precise working capital management. By analyzing the short-term financial leverage ratio, an investor assesses the proportion of liabilities maturing within one year relative to equity, where a sharp upward curve signals liquidity risk, while a decline confirms the resilience of the company's assets.

Who Organogenesis Holdings competes with

Short-Term Debt to Equity HCA Healthcare, Inc. (HCA)|THC (Tenet Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital FMS (Fresenius Medical Care)|solventum.com (SOLV) - Current Liabilities to Capital|Encompass Health Corporation - Short-Term Debt to Capital|UHS - Short-Term Debt to Capital|DVA (DaVita Inc) - Short-Term Debt to Equity Ratio|RDNT: Short-Term Loans to Capital Ratio|Short-Term Debt to Equity Option Care Health|Short-Term Debt to Equity Ratio surgerypartners.com (SGRY)|Short-Term Debt to Capital PINC|EYE - Current Liabilities to Capital|Short-Term Debt to Equity Progyny Health PGNY|ARDT: Short-Term Debt to Capital Ratio|SEM: Short-Term Debt to Equity Ratio|astranahealth.com - Short-Term Loans to Capital Ratio|MEDNAX (MD) - Short-Term Debt to Equity|Current Liabilities to Capital U.S. Physical Therapy, Inc. (USPH)|Short-Term Debt to Equity Pennant Group Inc|NUTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AUNA|SBC Medical Group Holdings Inc. (SBC) - Short-Term Indebtedness to Equity|Short-Term Debt to Capital EOLS (Evolus)|Short-Term Debt to Capital CHS CYH|SKIN - Short-Term Debt to Equity|MDWD (MediWound Ltd.) - Short-Term Debt to Capital Ratio|biote Corp. (BTMD) - Short-Term Debt to Equity|Current Liabilities to Capital thejoint.com (JYNT)|DCGO (DocGo) - Short-Term Debt to Capital|PIII - Short-Term Indebtedness to Equity|Short-Term Debt to Capital GANX|EUDA - Current Liabilities to Capital|Short-Term Debt to Equity Basel Medical Group Ltd BMGL|CLGN: Short-Term Debt to Capital Ratio|Cuprina Holdings - Short-Term Debt to Capital|Current Liabilities to Capital Concord Medical Services Holdings|American Shared Hospital Services, Inc. (AMS) - Short-Term Debt to Equity|MRM - Short-Term Debt to Capital Coefficient|ALBT (Avalon GloboCare Corp) - Short-Term Debt to Capital|dih.com (DHAI) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Carmell Therapeutics (XAGE)|Short-Term Debt to Capital Coefficient NewGenIvf Group|ATI Physical Therapy, Inc. - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital CMAX|Kindly MD, Inc. - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital MODV (modivcare.com)|Novo Integrated Sciences, Inc. (NVOS) - Short-Term Debt to Equity|Current Liabilities to Capital SunLink Health Systems, Inc. (SSY)|Short-Term Debt to Equity IMAC Regeneration Centers